[Federal Register Volume 62, Number 101 (Tuesday, May 27, 1997)]
[Notices]
[Pages 28722-28723]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-13829]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
Heart,

[[Page 28723]]

Lung, and Blood Special Emphasis Panel (SEP) meetings:

    Name of SEP: Mitochondrial Defects in Development of Cardiac 
Disease.
    Date: June 17-18, 1997.
    Time: 7:30 p.m.
    Place: Gaithersburg Marriott Washington Center, 9751 
Washingtonian Boulevard, Gaithersburg, Maryland 20878.
    Contact Person: Jon Ranhand, Ph.D., Two Rockledge Center, Room 
7188, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-0280.
    Purpose/Agenda: To review and evaluate grant applicants.

    Name of SEP: Human Anti-HIV Monoclonal Antibodies in 
Immunotherapy of HIV.
    Date: June 19-20, 1997.
    Time: 7:00 p.m.
    Place: Bethesda Mariott Hotel, 5151 Pooks Hill Road, Bethesda, 
Maryland 20814.
    Contact Person: Diane M. Reid, M.D., Two Rockledge Center, Room 
7182, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-0277.
    Purpose/Agenda: To review and evaluate grant applications.

    Name of SEP: POSH: Long-Term Mortality and Morbidity.
    Date: June 24, 1997.
    Time: 9:00 a.m.
    Place: Bethesda Holiday Inn, 8120 Wisconsin Avenue, Bethesda, 
Maryland 20814.
    Contact Person: C. James Scheirer, Ph.D., Two Rockledge Center, 
Room 7220, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-
0266.
    Purpose/Agenda: To review and evaluate grant applications.

    Name of SEP: Lung Health Study: Long-Term Followup.
    Date: June 24, 1997.
    Time: 1:30 p.m.
    Place: Bethesday Holiday Inn, 8120 Wisconsin Avenue, Bethesda, 
Maryland 20814.
    Contact Person: Anne P. Clark, Ph.D., Two Rockledge Center, Room 
7186, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-0280.
    Purpose/Agenda: To review and evaluate grant applications.

    Name of SEP: Demonstration and Education Research Applications 
(R18s) and Child and Adolescent Trial for Cardiovascular Health 
(UO1s).
    Date: July 22-23, 1997.
    Time: 9:00 a.m.
    Place: Washington National Airport Hilton, 2399 Jefferson Davis 
Highway, Arlington, Virginia 22202.
    Contact Person: Louise Corman, Ph.D., Two Rockledge Center, Room 
7180, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-0270.
    Purpose/Agenda: To review and evaluate grant applications.
    These meetings will be closed in accordance with the provisions 
set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
93.839 Blood Diseases and Resources Research, National Institutes of 
Health)

    Dated: May 20, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-13829 Filed 5-23-97; 8:45 am]
BILLING CODE 4140-01-M